Diabetes Masks Brain Changes in Alzheimer’s Patients
Diabetes can alter mitochondrial DNA levels, a finding that may change how future Alzheimer's studies are designed.
Updated on Oct. 21, 2026 in Alzheimer’s
Live Poll
Should medical studies routinely control for diabetes when researching Alzheimer's disease to improve diagnostic accuracy?
Researchers have discovered that diabetes significantly alters mitochondrial DNA levels in the brains of Alzheimer's patients, which may have previously obscured important findings. Distinguishing between these patients is now seen as essential for future dementia research and care strategies.
Why it matters
Including diabetic subjects in Alzheimer's data can mask disease-specific mitochondrial changes, complicating the understanding of how the brain function declines. Identifying these distinct biological markers is critical for developing more personalized treatment approaches.
A post-mortem brain study comparing mitochondrial DNA levels found that Alzheimer's patients without diabetes show a 19 to 30 percent reduction in copy number. Conversely, diabetic Alzheimer's patients exhibit significantly higher levels in the hippocampus, amygdala, and cerebellum.
The players
King's College London
A public research university where the team conducted this study on Alzheimer's disease and mitochondrial changes.
The details
The research team measured mitochondrial DNA copy number in post-mortem samples from the hippocampus, amygdala, and cerebellum. They found that diabetes is associated with higher mitochondrial DNA levels in the brain, which acts in opposition to the lower levels typically seen in Alzheimer's disease. By grouping patients with and without diabetes together, previous studies likely masked these distinct, disease-specific mitochondrial patterns.
Timeline
The research findings were published in the Alzheimer's & Dementia journal in 2026.
Health Landscape
This finding challenges the current standard of grouping all dementia patients together in clinical investigations. It suggests that future research and clinical trial designs must account for metabolic comorbidities like diabetes to accurately map Alzheimer's pathology.
If you or a loved one are managing both diabetes and memory concerns, discuss the implications of these metabolic factors with your neurologist or primary care physician. Understanding how multiple health conditions interact is a key part of your personalized care conversation.
The takeaway
Diabetes may physically alter mitochondrial DNA in the brain, which can hide distinct patterns associated with Alzheimer's disease. Patients and their caregivers should work with their doctors to ensure that their full medical history, including diabetes, is considered during dementia evaluations.
Further reading
For more on the latest research in the field, explore our Alzheimer’s section.
More information
View the complete study in Alzheimer's & Dementia journal to learn more about the research methodology.
Live Poll
Should medical studies routinely control for diabetes when researching Alzheimer's disease to improve diagnostic accuracy?
